Ozempic clinical trials After losing and regaining the same 20-plus pounds more times than she could count, Anita Blanchard concluded that diets don’t work. So when the University of North Carolina-Charlotte professor learned that Ozempic — developed to treat Type 2 diabetes — helped people lose weight and keep it off, Blanchard was determined to […]
Tag Archives: Ozempic renal function
Ozempic diabetes Blockbuster weight loss and type 2 diabetes drugs, such as Ozempic, carry a growing list of benefits. These drugs — known as glucagon-like peptide 1 (GLP-1) agonists — can control blood sugar, spur meaningful weight loss, and, in high-risk patients, help prevent heart attacks and strokes. US Food and Drug Administration approvals for […]
Ozempic coupon Surgery > Anesthesiology Ozempic coupon — Labels now caution about pulmonary aspiration risk by Kristen Monaco, Senior Staff Writer, MedPage Today November 8, 2024 Labels of all GLP-1 receptor agonists now carry a warning about pulmonary aspiration during general anesthesia or deep sedation. The warning affects all treatments containing GLP-1 receptor agonists, including […]
Ozempic benefits Neurology > Alzheimer’s Disease Ozempic benefits — Large observational study suggests further research is warranted by Judy George, Deputy Managing Editor, MedPage Today October 24, 2024 Semaglutide was linked with reduced Alzheimer’s risk among people with diabetes. The drug outperformed seven other diabetes medications in an observational study. GLP-1 drugs may target multiple […]
Ozempic healthcare provider Psychiatry > General Psychiatry Ozempic healthcare provider — Reports of suicidal ideation higher when compared to other drugs in WHO database by Kristen Monaco, Senior Staff Writer, MedPage Today August 20, 2024 A disproportionality analysis based on reports in a World Health Organization (WHO) database suggested a suicidal ideation signal with the […]
Ozempic clinical trials This story is part of a series called “Ozempic: Weighing the Risks and Benefits.” It was produced in part through a grant from the NIHCM Foundation. Looking at the data from clinical trials of new GLP-1 agonists, it’s clear that patients will need to stay on the drugs to maintain their weight […]
Ozempic doctor recommendation by Aude Bandini, Jean-Philippe Drouin-Chartier, Pierre-Marie David and Rémi Rabasa-Lhoret, The Conversation Credit: Pixabay/CC0 Public Domain The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the […]
Ozempic dosage On May 13, Sen. Bernie Sanders (I-Vt.) published an open letter to Novo Nordisk on the front page of a leading Danish newspaper, urging the hometown company to live up to its altruistic standards by lowering U.S. prices for its blockbuster diabetes and weight loss drugs. What Sanders didn’t realize was that Denmark, […]
Ozempic metabolism Two new studies show how eager Americans are to obtain either safe, legitimate versions of Ozempic or counterfeit and potentially dangerous forms of the diabetes/weight-loss drug. One study found U.S. prescriptions and refills of Ozempic (semaglutide) soaring over the past three years, jumping almost five-fold (392%) between early 2021 and the end of […]
Ozempic prescription Pulmonology > Smoking & Tobacco Ozempic prescription — Use for diabetes tied to fewer medical visits for tobacco use disorder versus other antidiabetics by Elizabeth Short, Staff Writer, MedPage Today, July 30, 2024 Among patients with type 2 diabetes and tobacco use disorder (TUD), use of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) […]